. Am. J. Pathol. 2005, 166, 1761771. 142. Gharbi-Ayachi, A.; Labbe, J.C.; Burgess, A.; Vigneron, S.; Strub, J.M.; Brioudes, E.; van-Dorsselaer, A.; Castro, A.; Lorca, T. The substrate of Greatwall kinase, Arpp 19, controls mitosis by inhibiting protein phosphatase 2A. Science 2010, 330, 1673677. 143. Mochida, S.; Maslen, S.L.; Skehel, M.; Hunt, T. Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is certainly essential for mitosis. Science 2010, 330, 1670673. 144. Bollen, M. Combinatorial handle of protein phosphatase-1. Trends Biochem. Sci. 2001, 26, 42631. 145. Rahman, A.; Grundke-Iqbal, I.; Iqbal, K. Phosphothreonine-212 of Alzheimer abnormally hyperphosphorylated tau is a preferred substrate of protein phosphatase-1. Neurochem. Res. 2005, 30, 27787. 146. Lapointe, N.E.; Morfini, G.; Pigino, G.; Gaisina, I.N.; Kozikowski, A.P.; Binder, L.I.; Brady, S.T. The amino terminus of tau inhibits kinesin-dependent axonal transport: Implications for filament toxicity. J. Neurosci. Res. 2009, 87, 44051. 147. Kanaan, N.M.; Morfini, G.A.; Lapointe, N.E.; Pigino, G.F.; Patterson, K.R.; Song, Y.; Andreadis, A.; Fu, Y.; Brady, S.T.; Binder, L.I. Pathogenic kinds of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases. J. Neurosci. 2011, 31, 9858868. 148. Liu, F.; Iqbal, K.; Grundke-Iqbal, I.; Rossie, S.; Gong, C.X. Dephosphorylation of tau by protein phosphatase five: Impairment in Alzheimer’s illness. J. Biol. Chem. 2005, 280, 1790796. 149. Yamaguchi, F.; Umeda, Y.; Shimamoto, S.; Tsuchiya, M.; Tokumitsu, H.; Tokuda, M.; Kobayashi, R. S100 Proteins Modulate Protein Phosphatase 5 Function: A link involving Ca2+ signal transduction and protein dephosphorylation. J. Biol. Chem. 2012, 287, 137873798. 150. Fedrizzi, L.; Carafoli, E. Ca2+ dysfunction in neurodegenerative disorders: Alzheimer’s disease. Biofactors 2011, 37, 18996. 151. Wasik, U.; Schneider, G.; Mietelska-Porowska, A.; Mazurkiewicz, M.; Fabczak, H.; Weis, S.; Zabke, C.; Harrington, C.R.; Filipek, A.; Niewiadomska, G. Calcyclin binding protein and Siah-1 interacting protein in Alzheimer’s illness pathology: Neuronal localization and possible function. Neurobiol. Aging 2013, 34, 1380388. 152. Kilanczyk, E.; Filipek, S.; Filipek, A. ERK1/2 is dephosphorylated by a novel phosphatase– CacyBP/SIP.(±)-Clopidogrel (bisulfate) Biochem.Moclobemide Biophys.PMID:23847952 Res. Commun. 2011, 404, 17983. 153. Diaz-Hernandez, M.; Gomez-Ramos, A.; Rubio, A.; Gomez-Villafuertes, R.; Naranjo, J.R.; Miras-Portugal, M.T.; Avila, J. Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau. J. Biol. Chem. 2010, 285, 325392548. 154. Necula, M.; Kuret, J. Pseudophosphorylation and glycation of tau protein improve but don’t trigger fibrillization in vitro. J. Biol. Chem. 2004, 279, 4969449703. 155. Smet-Nocca, C.; Broncel, M.; Wieruszeski, J.M.; Tokarski, C.; Hanoulle, X.; Leroy, A.; Landrieu, I.; Rolando, C.; Lippensa, G.; Hackenberger, C.P.R. Identification of O-GlcNAc websites inside peptides of your Tau protein and their impact on phosphorylation. Mol. BioSyst. 2011, 7, 1420429.Int. J. Mol. Sci. 2014,156. Yuzwa, S.A.; Macauley, M.S.; Heinonen, J.E.; Shan, X.; Dennis, R.J.; He, Y.; Whitworth, G.E.; Stubbs, K.A.; McEachern, E.J.; Davies, G.J.; et al. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 2008, 4, 48390. 157. Borghgraef, P.; Menuet, C.; Theunis, C.; Louis, J.V.; Devijver, H.; Maurin, H.;.
